Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Moderna Therapeutics

Moderna Therapeutics
2010 FOUNDED
PUBLIC STATUS
601-700 EMPLOYEES
MRNA STOCK SYMBOL
3 INVESTMENTS
$19.34 SHARE PRICE (As of Thursday Closing)
Description

Moderna Inc is engaged in creating transformative medicines based on messenger RNA, or mRNA. Its therapeutic and vaccine development programs span infectious diseases, oncology, cardiovascular diseases, and rare genetic diseases. The company's approach is to use mRNA medicines to instruct a patient's own cells to produce proteins that could prevent, treat, or cure disease.

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
NAS
Primary Office
  • 200 Technology Square
  • Cambridge, MA 02139
  • United States

+1 (617) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Moderna Therapeutics’s full profile, request a free trial.

Moderna Therapeutics Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$13.03 - $22.75 $6.55B $19.92 -$1.03 1.45M 329M

Moderna Therapeutics Financials Summary

In Thousands,
USD
TTM
30-Sep-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Revenue 191,551 205,825 108,396
EBITDA (279,750) (250,694) (211,366)
Net Income (281,252) (255,916) (216,211)
Total Assets 1,084,489 1,417,161
Total Debt 15,687 12,500
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Moderna Therapeutics Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Moderna Therapeutics‘s full profile, request access.

Request full access to PitchBook

Moderna Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is reserved for PitchBook Platform users. To explore Moderna Therapeutics‘s full profile, request access.

Request full access to PitchBook
To view this company’s complete Cap Table, request access »

Moderna Therapeutics Investments (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 22-Oct-2015 000000000 0000 Therapeutic Devices 00é00000 000000
0000000000 01-Jan-2015 000000000 00000 Biotechnology
Onkaido 14-Jan-2014 Corporate 0000 Drug Discovery
To view this company’s complete investment and acquisition history, request access »

Moderna Therapeutics Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000 22-Oct-2015 000000000 0000 Completed
  • 0000000 0000000000
Onkaido 14-Jan-2014 Corporate 0000 Completed
To view this company’s complete exits history, request access »

Moderna Therapeutics Subsidiaries (2)

Company Name Industry Location Founded
Valera Therapeutic Devices Cambridge, MA 2015
0000000 Drug Discovery Cambridge, MA 0000
To view this company’s complete subsidiary history, request access »

Moderna Therapeutics Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Moderna Therapeutics‘s full profile, request access.

Request full access to PitchBook

Moderna Therapeutics Executive Team (35)

Name Title Board
Seat
Contact
Info
Stéphane Bancel Chief Executive Officer & Board Member
Stephen Hoge MD President
John Mendlein Ph.D President of Corporate and Product Strategy
Lorence Kim MD Chief Financial Officer
Annie Drapeau Chief Human Resources Officer

15 Former Executives

You’re viewing 5 of 35 executives. Get the full list »

Moderna Therapeutics Board Members (16)

Name Representing Role Since Contact
Info
Elizabeth Nabel MD Moderna Therapeutics Board Member 000 0000
Henri Termeer Self Board Member 000 0000
Israel Ruiz Self Board Member 000 0000
Moncef Slaoui Ph.D Self Board Member 000 0000
Noubar Afeyan Ph.D Self Chairman & Co-Founder 000 0000

5 Former Board Members

You’re viewing 5 of 16 board members. Get the full list »